November 1, 2013
Daiichi Sankyo’s sales in the April-September period increased 6.7% from the same period last year to 516,413 million yen, thanks to the weaker yen and growing domestic sales of ethical drugs, particularly the proton pump inhibitor Nexium (esomeprazole). However, the...read more